TSS
TRAW icon

Two Sigma Securities’s Traws Pharma TRAW Stock Holding History

Two Sigma Securities’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,169
Closed -$25.4K – 2098
2025
Q2 		$25.4K Buy
+17,169
New +$27.4K ﹤0.01% 1171
2023
Q4 		– Sell
-437
Closed -$7.78K – 3701
2023
Q3 		$7.78K Buy
+437
New +$9.97K ﹤0.01% 2738
2023
Q2 		– Sell
-809
Closed -$14.8K – 3451
2023
Q1 		$14.8K Sell
809
-458
-36% -$9.91K ﹤0.01% 2401
2022
Q4 		$20.5K Buy
+1,267
New +$23.9K ﹤0.01% 2275
2020
Q2 		– Sell
-59
Closed -$7K – 1822
2020
Q1 		$7K Buy
59
+7
+13% +$1.1K ﹤0.01% 1255
2019
Q4 		$7K Buy
+52
New +$9.72K ﹤0.01% 2280

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's TRAW Position: Q3 2025 in Review

Two Sigma Securities sold out of Traws Pharma (TRAW) in Q3 2025, closing a stake of 17,169 shares — an estimated $25.4K sold.

Two Sigma Securities first reported a position in TRAW in Q4 2019 and held it in 6 quarters. The position peaked at $25.4K in Q2 2025. 18 funds tracked by Wall St. Rank hold TRAW as of Q3 2025.

  • Two Sigma Securities reported no remaining Traws Pharma position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 17,169 Traws Pharma shares in Q3 2025, an estimated $25.4K.
  • Two Sigma Securities first reported a position in Traws Pharma in Q4 2019 and held it in 6 quarters.
  • Two Sigma Securities's Traws Pharma position peaked at $25.4K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.